As an example, agonists for TLR3, TLR7, TLR8, and TLR9 have been shown to be capable of inhibiting HIV-1 infection and induced IFN-α-stimulated gene expression in PBMCs in vitro [37]. This evidence concerns the gene TLR9 and HIV-1 infection.